Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.

Maloney KW, Carroll WL, Carroll AJ, Devidas M, Borowitz MJ, Martin PL, Pullen J, Whitlock JA, Willman CL, Winick NJ, Camitta BM, Hunger SP.

Blood. 2010 Aug 19;116(7):1045-50. doi: 10.1182/blood-2009-07-235291. Epub 2010 May 4.

2.

A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.

Tigay JH.

J Pediatr Oncol Nurs. 2009 Nov-Dec;26(6):362-8. doi: 10.1177/1043454209340321. Review.

PMID:
20032297
3.

Targeting signaling pathways in acute lymphoblastic leukemia: new insights.

Harrison CJ.

Hematology Am Soc Hematol Educ Program. 2013;2013:118-25. doi: 10.1182/asheducation-2013.1.118. Review.

PMID:
24319172
4.

Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia.

Rubnitz JE.

J Biol Regul Homeost Agents. 2000 Jul-Sep;14(3):182-6. Review.

PMID:
11037050
5.
6.

How I treat ALL in Down's syndrome: pathobiology and management.

Izraeli S, Vora A, Zwaan CM, Whitlock J.

Blood. 2014 Jan 2;123(1):35-40. doi: 10.1182/blood-2013-07-453480. Epub 2013 Nov 14. Review.

7.

Epidemiology of childhood leukemia in the presence and absence of Down syndrome.

Mezei G, Sudan M, Izraeli S, Kheifets L.

Cancer Epidemiol. 2014 Oct;38(5):479-89. doi: 10.1016/j.canep.2014.07.006. Epub 2014 Aug 10. Review.

PMID:
25113940
8.

Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.

Harrison CJ.

Blood. 2015 Feb 26;125(9):1383-6. doi: 10.1182/blood-2014-08-569228. Epub 2015 Jan 21. Review.

9.

Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.

Brassesco MS, Xavier DJ, Camparoto ML, Montaldi AP, de Godoy PR, Scrideli CA, Tone LG, Sakamoto-Hojo ET.

J Biomed Biotechnol. 2011;2011. pii: 230481. doi: 10.1155/2011/230481. Epub 2010 Aug 31. Review.

10.

Malignancy in children with trisomy 21.

Rabin KR, Whitlock JA.

Oncologist. 2009 Feb;14(2):164-73. doi: 10.1634/theoncologist.2008-0217. Epub 2009 Jan 28. Review.

11.

New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.

Moorman AV.

Haematologica. 2016 Apr;101(4):407-16. doi: 10.3324/haematol.2015.141101. Review.

12.

The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.

Lee P, Bhansali R, Izraeli S, Hijiya N, Crispino JD.

Leukemia. 2016 Jul 8. doi: 10.1038/leu.2016.164. [Epub ahead of print] Review.

PMID:
27285583
13.

Advances in B-lymphoblastic leukemia: cytogenetic and genomic lesions.

Zhou Y, Kanagal-Shamanna R, Zuo Z, Tang G, Medeiros LJ, Bueso-Ramos CE.

Ann Diagn Pathol. 2016 Aug;23:43-50. doi: 10.1016/j.anndiagpath.2016.02.002. Epub 2016 Apr 9. Review. No abstract available.

PMID:
27130145
Items per page

Supplemental Content

Write to the Help Desk